$169.97
Price
$9.6B
Market Cap
8498.5
P/E Ratio
81.9
Forward P/E
$0.02
EPS (TTM)
—
Dividend Yield
$749M
Cash
$686M
Total Debt
56M
Shares Out
$102.97
$182.52
52-Week Range
Institutional Ownership of REPLIGEN CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for REPLIGEN CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for REPLIGEN CORP
6 Months Insider Sentiment
Buy $0
Sell $44K
0
Buys
1
Sells
-44K
Net
1
Grants
Largest
$88K
Muir
$44K
Dawes
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | Brian Robb Douglass | CHIEF PRODUCT OFFICER | GRANT | 2.3K | — | — |
| Dec 17, 2025 | Karen A Dawes | Director | SELL | 275 | $161.00 | $44K |
| Dec 16, 2025 | Glenn P Muir | Director | EXERCISE | 3.4K | $26.12 | $88K |